BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $5.29 million versus the consensus estimate of $5.23 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.